Skip to main content
Log in

Which Depressed Patients Should Receive Antidepressants?

  • Practical Therapeutics
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Antidepressants lead to improvement in about 70% of unselected patients with a depressive syndrome. However, many of these patients would also improve with the passage of time alone or with support and counselling. Although antidepressants are generally well tolerated, they can be expensive and are not devoid of adverse effects. Accordingly, it is worthwhile considering which patients are most likely to benefit from these drugs.

Patients who are likely to require antidepressants include those with a depression of relatively long duration, a depression of moderate or greater severity, and a depression that has melancholic or psychotic features. Patients with a history of previous depressive or manic episodes, and those showing suicidal ideation are also candidates for antidepressant treatment. Patients who show the sleep electroencephalographic (EEG) changes characteristic of depression and those with enhanced pituitary-adrenocortical activity usually require antidepressant treatment.

Once a depressed patient has responded to antidepressant treatment, further treatment for about 6 months is recommended to minimise the risk of relapse. Patients who are particularly vulnerable to recurrences may benefit from continuing antidepressant treatment beyond 6 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. US Department of Health and Human Services. Depression in primary care: treatment of major depression. Vol. 2, Clinical practice guideline No. 5. Washington, DC: US Government Printing Office, 1993

    Google Scholar 

  2. Brown WA, Johnson MF, Chen MG. Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res 1992; 41: 203–14

    Article  PubMed  CAS  Google Scholar 

  3. Fisher S, Greenberg RP. How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis 1993; 181: 345–50

    Article  PubMed  CAS  Google Scholar 

  4. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993; 150: 1–26

    Google Scholar 

  5. Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46: 89–99

    Article  PubMed  CAS  Google Scholar 

  6. Styron W. Darkness visible. New York: Random House, 1990: 37

    Google Scholar 

  7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1987

    Google Scholar 

  8. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403–11

    PubMed  CAS  Google Scholar 

  9. Khan A, Noonan C, Healey W. Is a single tricyclic antidepressant trial an active treatment for psychotic depression? Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 765–70

    Article  PubMed  CAS  Google Scholar 

  10. Peselow ED, Sanfilipo MP, Difiglia C, et al. Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 1992; 149: 1324–34

    PubMed  CAS  Google Scholar 

  11. Khan A, Brown WA. Who should receive antidepressants: suggestions from placebo treatment. Psychopharmacol Bull 1991; 27: 271–4

    PubMed  CAS  Google Scholar 

  12. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47: 1093–9

    Article  PubMed  CAS  Google Scholar 

  13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62

    Article  PubMed  CAS  Google Scholar 

  14. Qutikin FM, Stewart JW, McGrath PJ, et al. Columbia atypical depression. Br J Psychiatry 1993; 163 Suppl.: 30–4

    Google Scholar 

  15. Lewy AJ. Seasonal mood disorders. In: Dunner D, editor. Current psychiatric therapy. Philadelphia: WB Saunders Co, 1993: 220–5

    Google Scholar 

  16. Barraclough B, Bunch J, Nelson B, et al. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974; 125: 355–73

    Article  PubMed  CAS  Google Scholar 

  17. Ribiero SCM, Tandon R, Grunhaus L, et al. The DST as a predictor of outcome in depression; a meta-analysis. Am J Psychiatry 1993; 150: 1618–29

    Google Scholar 

  18. Thase ME, Simons AD, Reynolds CF. Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy. Psychopharmacol Bull 1993; 29: 293–301

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, W.A., Khan, A. Which Depressed Patients Should Receive Antidepressants?. CNS Drugs 1, 341–347 (1994). https://doi.org/10.2165/00023210-199401050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199401050-00004

Keywords

Navigation